Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10004920HBVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30002718HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30002719HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30000085HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30007101HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30015501HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30015502HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30015503HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30004637HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30015504HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TCGA Plot Options
Drug Information
GeneSTAT3
DrugBank IDDB16630
Drug NameOPB-111077
Target IDBE0003462
UniProt IDP40763
Regulation Typeinhibitor
PubMed IDs29511132
CitationsTolcher A, Flaherty K, Shapiro GI, Berlin J, Witzig T, Habermann T, Bullock A, Rock E, Elekes A, Lin C, Kostic D, Ohi N, Rasco D, Papadopoulos KP, Patnaik A, Smith L, Cote GM: A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers. Oncologist. 2018 Jun;23(6):658-e72. doi: 10.1634/theoncologist.2017-0325. Epub 2018 Mar 6.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL